Steven Van Steenweghen

Prognostic Value of Positron Emission Tomography (PET) With Fluorine-18 Fluorodeoxyglucose ([¹⁸F]FDG) After First-Line Chemotherapy in Non-Hodgkin’s Lymphoma: Is [¹⁸F]FDG-PET a Valid Alternative to Conventional Diagnostic Methods?

Karoline Spaepen, Sigrid Stroobants, Patrick Dupont et al. · Journal of Clinical Oncology · 2001 · 466 citations

Medicine, Nuclear Medicine, Oncology +17

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Tadeusz Robak, Jie Jin, Halyna Pylypenko et al. · The Lancet Oncology · 2018 · 140 citations

Medicine, Hematology, Oncology +15

Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes

Michel Delforge, Dominik Selleslag, Yves Béguin et al. · Leukemia Research · 2014 · 66 citations

Medicine, Hematology, Pharmacology +16

Mucormycosis, A Threatening Opportunistic Mycotic Infection

Steven Van Steenweghen, Johan Maertens, M. Boogaerts et al. · Acta Clinica Belgica · 1999 · 10 citations

Life Sciences, Infectious Diseases, Microbiology +17